Session Details

[S14★☆]Frontiers in Research on Idiosyncratic Drug-Induced Liver Injury
—Is it Possible to Predict Idiosyncratic Drug-Induced Liver Injury?—

Fri. Mar 27, 2026 1:10 PM - 3:10 PM JST
Fri. Mar 27, 2026 4:10 AM - 6:10 AM UTC
Room 09 (B401)
Organizer: Ryuji Kato (Osaka Med. Pharm. Univ.)

オーガナイザー挨拶
加藤 隆児(大阪医薬大薬)

[S14-1]Reactive drug metabolite-protein adducts and splenic macrophage-generated reactive oxygen species talk possible factors in idiosyncratic drug toxicity

○Tadatoshi Tanino1, Yukari Ueda1 (1. Fac. Pharm. Sci., Tokushima Bunri Univ.)

[S14-2]Strategies and Challenges in Mitigating Immune-Mediated Hepatotoxicity

○Tadahiro Shinozawa1 (1. Takeda Pharm. Co., Ltd.)

[S14-3]Comprehensive Proteomic Analysis for Molecular Risk Assessment of Drug-Induced Liver Injury Mediated by Reactive Metabolites

○Ryotaro Ban1, Mizuki Yamanaka2, Motoharu Kakiki1, Kazuko Inoue1, Takafumi Komori1, Saori Tanaka2, Ryuji Kato2 (1. Eisai Co., Ltd., 2. Osaka Med. Pharm. Univ.)

[S14-4]Can Damage-Associated Molecular Patterns (DAMPs) Serve as Predictive Markers for Drug-Induced Hepatotoxicity?

○Saori Tanaka1, Ryuji Kato1 (1. Osaka Med. Pharm. Univ.)

総合討論